Revenue of $2.0 billion; Record full year revenue of $7.5 billion, up 16% year-over-year adjusted for selected ...

GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...

The Federal Government has announced plans to deploy up to 30 kilometres of fibre-optic infrastructure across the Obafemi ...

Thales has opened a new cortAIx AI accelerator site in Germany, expanding its global network to five locations and reinforcing its focus on trustworthy AI for critical defence and security systems.